Editorial Contributor

Aaron Kowalski, PhD

Diabetes Researcher
Assistant Vice President, Treatment Therapies
Juvenile Diabetes Research Foundation

Aaron J. Kowalski, Ph.D., oversees JDRF-funded research aimed at accelerating the delivery of therapies that will help keep people healthy while living with type 1 diabetes, minimizing their risk for developing diabetes complications, as well as therapies that will help those who have developed diabetic complications. Dr. Kowalski is an internationally recognized expert in the area of diabetes technologies and has been a leader of JDRF’s Artificial Pancreas Project, a multi-million dollar initiative that began in 2005 to accelerate the progress toward a closed-loop automated insulin-delivery system. He has authored numerous articles in the field and was a co-author of the landmark study in The New England Journal of Medicine which revealed the effectiveness of continuous glucose monitors in type 1 diabetes. Dr. Kowalski has traveled widely across North America and abroad describing diabetes research progress, and is known for his ability to translate science into easily understandable concepts.
 
Dr. Kowalski has been an invited speaker at many national and international conferences, including the ADA Annual Scientific Sessions, and was the keynote speaker at the 2009 Diabetes Technology Society Meeting. He has been a voice for diabetes research in the popular media, appearing on The Martha Stewart Show, dLife, Fox Business, NPR, and many other shows, and is often quoted in print media including The New York Times, The Wall Street Journal, USA Today, and People magazine. He earned his doctorate in molecular genetics from Rutgers University and the University of Medicine and Dentistry of New Jersey.